1-hydroxymethylmidazolam has been researched along with Hypoalbuminemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baar, FPM; de Winter, BCM; Franken, LG; Koch, BCP; Masman, AD; Mathot, RAA; Tibboel, D; van Gelder, T | 1 |
1 trial(s) available for 1-hydroxymethylmidazolam and Hypoalbuminemia
Article | Year |
---|---|
Hypoalbuminaemia and decreased midazolam clearance in terminally ill adult patients, an inflammatory effect?
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Dosage Calculations; Female; Glomerular Filtration Rate; Humans; Hypnotics and Sedatives; Hypoalbuminemia; Injections, Subcutaneous; Male; Metabolic Clearance Rate; Midazolam; Middle Aged; Nonlinear Dynamics; Palliative Care; Precision Medicine; Renal Elimination; Terminally Ill; Time Factors | 2017 |